Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), today announced that it will be presenting two rapid-fire presentations at CHEST 2025, the annual meeting of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback